Evaluating the updated LATE‐NC staging criteria using data from NACC
Alzheimer's & Dementia · 2024-12 · 20 (12) · 8359-8373
DOI: 10.1002/alz.14262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024-10. Verfasst von Davis C Woodworth und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California, Irvine, California, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH NIA.
Abstract (Originalsprache)
INTRODUCTION Limbic‐predominant age‐related TAR DNA‐binding protein of 43 kDa encephalopathy neuropathologic change (LATE‐NC) staging criteria were updated in 2023. We evaluated this updated staging using National Alzheimer's Coordinating Center data. METHODS We examined associations of LATE‐NC stages with cognition and other neuropathologic changes (NCs), and with cognition while accounting for other NCs, using multilevel regression models. RESULTS Of 1352 participants, 502 (37%) had LATE‐NC (23% stage 1a, 6% stage 1b, 58% stage 2, 13% stage 3). LATE‐NC stages were associated with cognition, hippocampal sclerosis of aging (HS‐A), Alzheimer's disease NC (ADNC), Lewy bodies (LBs), and hippocampal atrophy. While stage 1b was associated with cognition and HS‐A consistent with other stages, it was not associated with ADNC or LBs. All LATE‐NC stages remained significantly associated with worse cognition when accounting for other NCs. DISCUSSION The updated LATE‐NC staging criteria capture variations in early TDP‐43 pathology spread which are consequential for cognition and associations with other NCs. Highlights We applied the updated limbic‐predominant age‐related TAR DNA‐binding protein of 43 kDa encephalopathy neuropathologic change (LATE‐NC) staging criteria to data from the National Alzheimer's Coordinating Center. LATE‐NC stage 1b was identified in 22% of participants with stage 1. In contrast to other LATE‐NC stages, stage 1b was not associated with Alzheimer's disease neuropathologic change (ADNC) or Lewy bodies. Stages 1a and 1b were significantly associated with dementia and memory impairment. Stages 1b+ were more strongly tied to dementia than all other neuropathologic changes except high likelihood ADNC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of California, Irvine, California, USA.
- Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, California, USA.
- Department of Pathology and Laboratory Medicine, University of California, Irvine, California, USA.
- Department of Neurobiology and Behavior, University of California, Irvine, California, USA.
- Department of Epidemiology and Biostatistics, University of California, Irvine, California, USA.
- Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, Kentucky, USA.
Förderung
- NIA NIH HHS
- NIH NIA
Zitieren
APA
Woodworth, D. C., Nguyen, K. M., Sordo, L., Scambray, K. A., Head, E., Kawas, C. H., Corrada, M. M., Nelson, P. T., & Sajjadi, S. A. (2024). Evaluating the updated LATE‐NC staging criteria using data from NACC. Alzheimer's & Dementia, 20(12), 8359-8373. https://doi.org/10.1002/alz.14262
Vancouver
Woodworth DC, Nguyen KM, Sordo L, Scambray KA, Head E, Kawas CH, et al. Evaluating the updated LATE‐NC staging criteria using data from NACC. Alzheimer's & Dementia. 2024;20(12):8359-8373. doi:10.1002/alz.14262
BibTeX
@article{Woodworth2024,
author = {Woodworth, Davis C and Nguyen, Katelynn M and Sordo, Lorena and Scambray, Kiana A and Head, Elizabeth and Kawas, Claudia H and Corrada, María M and Nelson, Peter T and Sajjadi, S Ahmad},
title = {Evaluating the updated LATE‐NC staging criteria using data from NACC},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {12},
pages = {8359--8373},
doi = {10.1002/alz.14262}
}
EUVIMED